This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sanford Heisler Adds Four New Class Representatives To $250M Gender Discrimination Class Action Suit Against Pharma Giant Merck

NEWARK, N.J., Jan. 17, 2014 /PRNewswire/ -- Sanford Heisler LLP today added four additional class representatives to the class action gender discrimination employment suit the firm filed in U.S. District Court for New Jersey against pharmaceutical giant Merck & Co., Inc. in May 2013. The firm also increased the value of the case to $250 million.

The suit's original class representative Kelli Smith has been joined by female sales representatives from Merck locations coast to coast who also experienced discrimination based on their gender and pregnancy. Merck fosters a "boys' club" culture that affords men greater advancement opportunities and greater pay. Merck management discourages women from raising complaints of discrimination, instead telling them to "lie" to Human Resources. When women do complain within the company's internal channels, their complaints go ignored.

"The addition of four female Merck sales representatives as class representatives is further evidence of the pervasive nature of gender-based hostility throughout Merck's U.S. sales force," said Kate Mueting, attorney with the plaintiffs' legal team. "All of these women have experienced disastrous and painful career consequences as a result of Merck's policies that discourage female employees from having children and punish those who do. This class action brings light to this discrimination and aims to prevent the company from future discrimination."

Other members of the legal team at Sanford Heisler include David Sanford, Chairman of the firm; and Deborah Marcuse and Jennifer Siegel, attorneys in Sanford Heisler's New York office.

Sanford Heisler LLP has a long record of victories in employment discrimination matters brought by female employees of global pharmaceutical companies, including a recent gender discrimination case against Novartis that resulted in the largest-ever monetary award in a U.S. employment discrimination dispute.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.91 +93.33 0.53%
S&P 500 2,081.34 +12.58 0.61%
NASDAQ 4,997.4590 +5.5190 0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs